CL (Colgate-Palmolive Company)
Insider Trading Activity
Every open-market purchase and sale reported by CL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-26 | Panagiotis Tsourapas | COO, CD, EMEA, APac, Skin | Sell | — | — |
| 2026-08-07 | JOHN T CAHILL | Director | MIXED | — | — |
| 2026-08-07 | JOHN T CAHILL | Director | MIXED | — | — |
| 2026-08-06 | Noel R. Wallace | Chairman, President & CEO | MIXED | — | — |
| 2026-08-06 | Noel R. Wallace | Chairman, President & CEO | MIXED | — | — |
| 2026-07-02 | LORRIE M NORRINGTON | Director | A | — | — |
| 2026-07-02 | JOHN P BILBREY | Director | A | — | — |
| 2026-07-02 | Brian Newman | Director | A | — | — |
| 2026-06-17 | SHANE GRANT | COO, Americas | F | — | — |
| 2026-05-18 | Gregory Malcolm | EVP and Controller | Sell | — | — |
| 2026-05-13 | JOHN P BILBREY | Director | A | — | — |
| 2026-05-13 | CHRISTOPHER S. BOERNER | Director | A | — | — |
| 2026-05-13 | JOHN T CAHILL | Director | A | — | — |
| 2026-05-13 | Lisa Edwards | Director | A | — | — |
| 2026-05-13 | C MARTIN HARRIS | Director | A | — | — |
| 2026-05-13 | LORRIE M NORRINGTON | Director | A | — | — |
| 2026-05-13 | MARTINA HUNDMEJEAN | Director | A | — | — |
| 2026-05-13 | Kimberly A Nelson | Director | A | — | — |
| 2026-05-13 | Brian Newman | Director | A | — | — |
| 2026-05-11 | Sally Massey | Chief People Officer | Sell | — | — |
| 2026-04-03 | JOHN P BILBREY | Director | A | — | — |
| 2026-04-03 | Brian Newman | Director | A | — | — |
| 2026-04-03 | LORRIE M NORRINGTON | Director | A | — | — |
| 2026-02-25 | Noel R. Wallace | Chairman, President & CEO | MIXED | — | — |
| 2026-02-25 | Panagiotis Tsourapas | COO, Eur., APac, Afr Eur, Skin | MIXED | — | — |
| 2026-02-25 | STANLEY J III SUTULA | Chief Financial Officer | MIXED | — | — |
| 2026-02-25 | Sally Massey | Chief Human Resources Officer | MIXED | — | — |
| 2026-02-25 | Gregory Malcolm | EVP and Controller | MIXED | — | — |
| 2026-02-25 | Jennifer Daniels | CLO and Secretary | MIXED | — | — |
| 2026-02-25 | John Hazlin | Chief Growth Officer | MIXED | — | — |
| 2026-02-13 | Panagiotis Tsourapas | COO, Eur., APac, Afr Eur, Skin | MIXED | — | — |
| 2026-02-12 | John Hazlin | Chief Growth Officer | MIXED | — | — |
| 2026-02-10 | Gregory Malcolm | EVP and Controller | MIXED | — | — |
| 2026-02-09 | Sally Massey | Chief Human Resources Officer | MIXED | — | — |
| 2026-02-06 | Noel R. Wallace | Chairman, President & CEO | Sell | — | — |
| 2026-02-06 | Jennifer Daniels | CLO and Secretary | MIXED | — | — |
| 2026-02-06 | STANLEY J III SUTULA | Chief Financial Officer | MIXED | — | — |
| 2026-01-06 | JOHN P BILBREY | Director | A | — | — |
| 2026-01-06 | LORRIE M NORRINGTON | Director | A | — | — |
| 2026-01-06 | Brian Newman | Director | A | — | — |
| 2025-12-05 | Jennifer Daniels | CLO and Secretary | F | — | — |
| 2025-12-05 | John Hazlin | Chief Growth Officer | F | — | — |
| 2025-12-05 | Gregory Malcolm | EVP and Controller | F | — | — |
| 2025-12-05 | STANLEY J III SUTULA | Chief Financial Officer | F | — | — |
| 2025-12-05 | Panagiotis Tsourapas | COO, Eur., APac, Afr Eur, Skin | F | — | — |
| 2025-12-05 | Noel R. Wallace | Chairman, President & CEO | F | — | — |
| 2025-11-24 | Sally Massey | Chief Human Resources Officer | Sell | — | — |
| 2025-10-03 | JOHN P BILBREY | Director | A | — | — |
| 2025-10-03 | LORRIE M NORRINGTON | Director | A | — | — |
| 2025-10-03 | Brian Newman | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 13,824,660 | — |
| — | Vice Chairman | 1,129,982 | — |
| — | Executive Chairman | 1,036,805 | — |
| — | Vice Chairman | 581,050 | — |
| — | CEO, Hill's Pet Nutrition | 508,372 | — |
| — | Vice Chairman | 474,891 | — |
| — | Chairman, President & CEO | 362,566 | — |
| — | Vice Chairman | 339,462 | — |
| — | VP Fin.&Strat.Plan.Lat.Am. | 264,445 | — |
| — | Vice Chairman | 220,242 | — |
| — | Director | 206,756 | — |
| — | Vice Chairman | 187,480 | — |
| — | SrVP Investor Relations | 169,957 | — |
| — | Chief Financial Officer | 155,621 | — |
| — | COO G1.Innov.&Gwth,Eur.&Hill's | 139,763 | — |
| — | Exec VP, Chief Gwth&Strtgy Off | 138,909 | — |
| — | Sr. VP Glob. I.T. & Bus. Serv. | 129,924 | — |
| — | Director | 124,774 | — |
| — | VP-Chief Ethics & Compliance | 122,024 | — |
| — | Exec VP Pres. No. Am. & W.C.E. | 111,924 | — |
| — | Director | 111,724 | — |
| — | Vice President and Controller | 109,783 | — |
| — | CLO and Secretary | 104,032 | — |
| — | Pres. Colgate Greater Asia | 102,868 | — |
| — | VP-Global Supply Chain | 101,204 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CL quote page; the site-wide leaderboard is on the insider transactions hub.